Fig. 1 · Structure
Documents & Downloads
DNK-333
NK1/NK2 Receptor Antagonist
DNK-333 is a potent dual antagonist of the NK1 and NK2 receptors, exhibiting IC50 values of 4.8 nM and 5.5 nM, respectively. This compound effectively inhibits Neurokinin A (NKA)-induced bronchoconstriction, making it a valuable tool for research on respiratory conditions such as asthma. Its balanced activity at both receptor sites allows for exploring therapeutic strategies targeting neurokinin signaling pathways.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Antagonist |
| CAS Number | 398507-81-8 |
| Applications | NK1/NK2 Receptor Antagonist |
| Formula | C27H25Cl2F6N3O3 |
| Molecular Weight | 624.40 |
| SMILES | O=C(N([C@H](CC1=CC(Cl)=C(Cl)C=C1)/C=C/C(N[C@H]2C(NCCCC2)=O)=O)C)C3=CC(C(F)(F)F)=CC(C(F)(F)F)=C3 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.